Australia has made a groundbreaking decision by becoming the first country to legalise the clinical prescribing of MDMA (ecstasy) and…
The medicinal cannabis industry in Australia has been rapidly gaining momentum, reaching an estimated value of approximately $245 million in…
This quarter has been a busy one for Australian cannabis distributor Cann Group (ASX: CAN), evident in the Company’s sales…
Since the easing of regulatory red tape and wider societal acceptance of utilising cannabis for its medical properties, the medicinal…
In an incident which can only be described with a 🤦♂️, shareholders of cannabis company Cann Group (ASX: CAN) are…
Medical cannabis producer, Cann Group Limited (ASX: CAN) have announced this morning their response to yesterday's price query from the…